News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
294,920 Results
Type
Article (7540)
Company Profile (30)
Press Release (287350)
Section
Business (99807)
Career Advice (611)
Deals (18396)
Drug Delivery (15)
Drug Development (28575)
Employer Resources (48)
FDA (5202)
Job Trends (5617)
News (153117)
Policy (10988)
Tag
2024 BioCapital Digital (2)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Standard (2)
2024 Genetown Digital (1)
2024 Genetown Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (2)
2025 Lone Star Bio Digital (1)
Academia (628)
Adcomms (3)
Allergies (16)
Alliances (21028)
ALS (25)
Alzheimer's disease (381)
Antibody-drug conjugate (ADC) (20)
Approvals (5217)
Artificial intelligence (172)
Autoimmune disease (3)
Automation (6)
Bankruptcy (142)
Best Places to Work (4480)
BIOSECURE Act (3)
Biosimilars (17)
Biotechnology (31)
Bladder cancer (14)
Brain cancer (8)
Breast cancer (70)
Cancer (627)
Cardiovascular disease (39)
Career advice (518)
Career pathing (6)
CAR-T (37)
Cell therapy (134)
Cervical cancer (4)
Clinical research (23743)
Collaboration (278)
Compensation (147)
Complete response letters (4)
COVID-19 (498)
CRISPR (18)
C-suite (95)
Cystic fibrosis (26)
Data (714)
Decentralized trials (1)
Denatured (7)
Depression (9)
Diabetes (67)
Diagnostics (2983)
Digital health (11)
Diversity, equity & inclusion (16)
Drug discovery (38)
Drug pricing (11)
Drug shortages (1)
Duchenne muscular dystrophy (14)
Earnings (46687)
Editorial (3)
Employer branding (8)
Employer resources (46)
Events (46728)
Executive appointments (326)
FDA (5553)
Featured Employer (11)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (5)
Funding (240)
Gene editing (37)
Generative AI (13)
Gene therapy (71)
GLP-1 (143)
Government (720)
Guidances (23)
Healthcare (7193)
Huntington's disease (4)
IgA nephropathy (8)
Immunology and inflammation (19)
Indications (7)
Infectious disease (525)
Inflammatory bowel disease (40)
Inflation Reduction Act (3)
Influenza (13)
Intellectual property (60)
Interviews (91)
IPO (9229)
IRA (4)
Job creations (1295)
Job search strategy (461)
Kidney cancer (7)
Labor market (6)
Layoffs (126)
Leadership (6)
Legal (3277)
Liver cancer (22)
Lung cancer (81)
Lymphoma (44)
Machine learning (2)
Management (14)
Manufacturing (75)
MASH (30)
Medical device (5476)
Medtech (5478)
Mergers & acquisitions (9412)
Metabolic disorders (172)
Multiple sclerosis (17)
NASH (6)
Neurodegenerative disease (14)
Neuropsychiatric disorders (3)
Neuroscience (512)
NextGen: Class of 2025 (2254)
Non-profit (997)
Northern California (1102)
Now hiring (5)
Obesity (76)
Opinion (68)
Ovarian cancer (23)
Pain (19)
Pancreatic cancer (26)
Parkinson's disease (34)
Partnered (7)
Patents (106)
Patient recruitment (29)
Peanut (6)
People (28760)
Pharmaceutical (7)
Pharmacy benefit managers (1)
Phase I (7321)
Phase II (10527)
Phase III (7967)
Pipeline (486)
Podcasts (9)
Policy (13)
Postmarket research (791)
Preclinical (2917)
Press Release (67)
Prostate cancer (30)
Psychedelics (6)
Radiopharmaceuticals (125)
Rare diseases (88)
Real estate (2159)
Recruiting (20)
Regulatory (7500)
Reports (15)
Research institute (590)
Resumes & cover letters (82)
Rett syndrome (2)
RSV (3)
Schizophrenia (22)
Series A (30)
Series B (26)
Service/supplier (4)
Sickle cell disease (9)
Southern California (881)
Special edition (3)
Sponsored (8)
Startups (1377)
Stomach cancer (1)
Supply chain (16)
The Weekly (2)
United States (8753)
Vaccines (89)
Venture capitalists (5)
Webinars (6)
Weight loss (23)
Women's health (3)
Worklife (2)
Date
Today (75)
Last 7 days (372)
Last 30 days (1346)
Last 365 days (15459)
2025 (2535)
2024 (16016)
2023 (18933)
2022 (26514)
2021 (28587)
2020 (25727)
2019 (18416)
2018 (13963)
2017 (13581)
2016 (11975)
2015 (15447)
2014 (11879)
2013 (9255)
2012 (10304)
2011 (10836)
2010 (10474)
Location
Africa (251)
Alabama (17)
Alaska (2)
Arizona (72)
Arkansas (4)
Asia (16444)
Australia (2521)
California (2370)
Canada (954)
China (130)
Colorado (97)
Connecticut (111)
Delaware (35)
Europe (32476)
Florida (314)
Georgia (40)
Idaho (31)
Illinois (197)
India (7)
Indiana (112)
Japan (79)
Kansas (26)
Kentucky (10)
Louisiana (6)
Maine (41)
Maryland (278)
Massachusetts (1776)
Michigan (118)
Minnesota (152)
Mississippi (1)
Missouri (39)
Montana (23)
Nebraska (13)
Nevada (23)
New Hampshire (24)
New Jersey (648)
New Mexico (9)
New York (696)
North Carolina (383)
North Dakota (2)
Northern California (1102)
Ohio (63)
Oklahoma (6)
Oregon (3)
Pennsylvania (505)
Rhode Island (16)
South America (370)
South Carolina (4)
Southern California (881)
Tennessee (37)
Texas (400)
Utah (73)
Virginia (40)
Washington D.C. (18)
Washington State (186)
West Virginia (2)
Wisconsin (19)
294,920 Results for "intel corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Former Apple and Intel Executive Michael Bell Joins Chemify as Chief Technology Officer
February 27, 2025
·
2 min read
Biotech Bay
Intel Labs to Present Industry-Leading AI Research at NeurIPS 2023
Intel Labs is showcasing some of its most significant and industry-first AI innovations at NeurIPS 2023 — the leading global event for developers, researchers, and academic professionals focused on AI and computer-vision technologies.
December 11, 2023
·
4 min read
Business
Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors
Renovaro Biosciences Inc., a biotechnology corporation focusing on cell, gene, and immunotherapy, has announced that Avram Miller will join its Board of Directors.
October 11, 2023
·
8 min read
Press Releases
Bionoid Pharma, Inc. Provides Corporate Update and Outlines Growth Strategy for 2025
January 14, 2025
·
1 min read
Press Releases
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
March 4, 2025
·
13 min read
Pharm Country
Amplity Health’s Breakthrough AI-driven Platform Offers Pharma Leaders Actionable Intel During Crucial Drug Launch Window
Contract Medical and Commercial Organization, Amplity Health has released a revolutionary AI-driven next best action solution that provides pharmaceutical and biopharmaceutical companies with an entirely new order of field insights that can be acted upon within the earliest days of a drug’s release.
December 6, 2023
·
5 min read
Press Releases
Mesoblast Financial Results and Corporate Update Webcast
February 26, 2025
·
2 min read
Genetown
Intel Capital and Khosla Ventures Lead $27M Investment in SiPhox® Health to Transform Health Testing
SiPhox Health, the leader in building the next generation of lab-grade home health testing with silicon photonics, raised $27 million in funding including a $10M Seed financing and a $17M Series A round.
July 19, 2023
·
4 min read
Press Releases
Orion Corporation: The Board of Directors of Orion Corporation decided on incentive programs for the company’s key persons
February 25, 2025
·
3 min read
Press Releases
OS Therapies Provides Corporate Update
February 4, 2025
·
14 min read
1 of 29,492
Next
